A pilot clinical trial to determine the potentials of a 3-day, 200 mg 6 hourly course of Rifaximin by comparing its efficacy with that of a 3-day, 500 mg 12 hourly dose of ciprofloxacin in the treatment of adults with clinically severe cholera due to V. cholerae O1 or O139

Simple item page
dc.contributor.authorSalam, M.A.
dc.date.accessioned2012-11-15T05:29:28Z
dc.date.available2012-11-15T05:29:28Z
dc.date.issued2005
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/4123
dc.identifier.urihttp://hdl.handle.net/123456789/4123
dc.language.isoen
dc.sourceICDDR,B Institutional Repository
dc.subjectVibrio cholerae
dc.subjectCiprofloxacin
dc.subjectBangladesh
dc.titleA pilot clinical trial to determine the potentials of a 3-day, 200 mg 6 hourly course of Rifaximin by comparing its efficacy with that of a 3-day, 500 mg 12 hourly dose of ciprofloxacin in the treatment of adults with clinically severe cholera due to V. cholerae O1 or O139
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ICDDRBProtocol-2005-009.doc
Size:
388.5 KB
Format:
Adobe Portable Document Format
Download

Collections

Clinical sciences research protocols